TechCrunch LA

OCTOBER 19, 2019

It echoes the same message from Kik’s chief executive Tim Livingston last week when he rebuffed earlier reports that the company would shut down amid an ongoing battle with the U.S. In a post on Kik’s blog on Friday the MediaLab said that it has “finalized an agreement” to acquire Kik Messenger.

Social Network 153

Social Network Los Angeles Social Media Blogging 153

Both Sides of the Table

JANUARY 26, 2013

One of the advantages of blogging, using social media, public speaking, etc as a VC is that you get a more nuanced view of these shifts by watching your own successes and failures. The problem is that this is publicly available information that can and will be scanned by journalists and reported. When you file, you must be prepared.

Startup 355

Startup Funding News Press 355

Xconomy

OCTOBER 7, 2016

—The Institute for Clinical and Economic Review (ICER), whose drug-value analyses set the pharma industry’s teeth on edge , issued a new report on PD-1 inhibitors , part of the first wave of cancer immunotherapy drugs to be approved. . —The Nobel in Chemistry went to three scientists, in France, the Netherlands, and the U.S.,

Technical Review 77

Technical Review Study Layoffs San Diego 77

Xconomy

JULY 1, 2016

If you want fireworks this weekend, you can either celebrate the 4th of July or watch the latest post-Brexit political developments in Britain. But as Xconomy reported, details about the reorganization were scant, leaving open questions whether drug regulation actually needs to move faster.

Buzzfeed 59

Buzzfeed News Pricing IBM 59

Xconomy

JULY 1, 2016

Layoffs Reflect New Turbulence at High-Flying 3D Robotics. Frank Vinluan reports from North Carolina on a new effort to boost agtech startups and university research. The Xconversation: Vaccine Developer Meets Energy Innovator. Time to look back on the past six months—and some of the top stories of the year so far.

Artificial Inteligence 40

Artificial Inteligence Layoffs Report Startup 40

Xconomy

JULY 15, 2016

The company began a Phase 1 trial last year for an irritable bowel disease treatment…Gene therapy developer Audentes Therapeutics said it would try for a $75 million IPO …Scarsdale, NY-based Sapience Therapeutics raised a $22.5 —Enough good trial news. million in funding, according to a regulatory filing. . —With $1.25

News 40

News Technical Review San Diego Startup 40